Meningioma as second malignant neoplasm after oncological treatment during childhood
✍ Scribed by H.L. Müller; U. Gebhardt; M. Warmuth-Metz; T. Pietsch; N. Sörensen; R.-D. Kortmann; on behalf of the study committee of HIT Endo
- Book ID
- 113015482
- Publisher
- Springer
- Year
- 2012
- Tongue
- German
- Weight
- 547 KB
- Volume
- 188
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The aim of our study was to quantify the risk of second malignant neoplasms (SMNs) among long‐term survivors of neuroblastoma and to study the influence of treatment on this risk. We studied data from 544 5‐year survival patients diagnosed with neuroblastoma before age 16 years at 8 Fre
The risk of second malignant neoplasm (SMN) was evaluated in 979 children with Hodgkin's disease. This cohort was diagnosed between 1955 and 1979 at one of the institutions of the Late Effects Study Group. Solid tumors, non-lymphocytic leukemia, and non-Hodgkin's lymphoma (NHL) developed in 18, 17,